Literature DB >> 7793317

Rel/NF-kappa B/I kappa B story.

S Miyamoto1, I M Verma.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793317

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  70 in total

1.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

2.  The protein kinase PKR: a molecular clock that sequentially activates survival and death programs.

Authors:  Olivier Donzé; Jing Deng; Joseph Curran; Robert Sladek; Didier Picard; Nahum Sonenberg
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

3.  Nuclear factor kappaB controls acetylcholine receptor clustering at the neuromuscular junction.

Authors:  Jia Wang; Xiu-Qing Fu; Wen-Liang Lei; Tong Wang; Ai-Li Sheng; Zhen-Ge Luo
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

4.  Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.

Authors:  B Piret; J Piette
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

5.  Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation.

Authors:  J L Cheshire; A S Baldwin
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

6.  A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.

Authors:  Z Li; G J Nabel
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

7.  TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB.

Authors:  A Yamit-Hezi; R Dikstein
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 8.  The multifaceted NF-kB: are there still prospects of its inhibition for clinical intervention in pediatric central nervous system tumors?

Authors:  Mariana Medeiros; Marina Ferreira Candido; Elvis Terci Valera; María Sol Brassesco
Journal:  Cell Mol Life Sci       Date:  2021-07-31       Impact factor: 9.261

9.  Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors:  Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Apoptosis induced by the histone deacetylase inhibitor FR901228 in human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.

Authors:  Naoki Mori; Takehiro Matsuda; Masayuki Tadano; Takao Kinjo; Yasuaki Yamada; Kunihiro Tsukasaki; Shuichi Ikeda; Yoshihiro Yamasaki; Yuetsu Tanaka; Takao Ohta; Teruo Iwamasa; Masao Tomonaga; Naoki Yamamoto
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.